| Healthcare and Medical Technology |
1 |
1 |
| Microbiome |
0 |
0.99 |
| Bacteria |
0 |
0.58 |
| Cardiovascular Risk Management |
0 |
0.4 |
| Skin and Soft Tissue Infection |
0 |
0.4 |
| Coronary Artery Disease (CAD) |
0 |
0.32 |
| Heart Failure (HF) |
0 |
0.31 |
| Blood |
0 |
0.27 |
| Probiotics |
0 |
0.27 |
| Complementary and Alternative Medicine |
0 |
0.24 |
| Chronic Kidney Disease |
0 |
0.23 |
| Artificial Intelligence |
0 |
0.22 |
| Bile |
0 |
0.22 |
| Diet |
0 |
0.22 |
| Future of Medicine |
0 |
0.22 |
| Mobile Health |
0 |
0.22 |
| Renal Disease |
0 |
0.22 |
| Cardiovascular disease |
0 |
0.18 |
| Heart |
0 |
0.18 |
| Liver |
0 |
0.18 |
| Renal Failure |
0 |
0.17 |
| Depression |
0 |
0.16 |
| Liver Disease |
0 |
0.16 |
| Obesity |
0 |
0.16 |
| Pregnancy |
0 |
0.16 |
| Metabolic Syndrome |
0 |
0.15 |
| Clinical Research |
0 |
0.13 |
| Estrogen |
0 |
0.13 |
| Metabolism |
0 |
0.13 |
| Receptors |
0 |
0.13 |
| Atherosclerosis |
0 |
0.12 |
| Lipids Management |
0 |
0.12 |
| Biologic Therapy |
0 |
0.11 |
| Postpartum Depression |
0 |
0.11 |
| Toxicology |
0 |
0.1 |
| Cancer |
0 |
0.09 |
| Diversity |
0 |
0.09 |
| Fatty Acids |
0 |
0.09 |
| Genomic Medicine |
0 |
0.09 |
| Iowa |
0 |
0.09 |
| Kidney |
0 |
0.09 |
| Mood Disorders |
0 |
0.09 |
| Pain Management |
0 |
0.09 |
| Testosterone |
0 |
0.09 |
| Texas |
0 |
0.09 |
| Travel Medicine |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.08 |
| Crohn Disease |
0 |
0.07 |
| Multiple Sclerosis |
0 |
0.07 |
| Clostridium Difficile Infection |
0 |
0.06 |
| Complex Regional Pain Syndrome |
0 |
0.06 |
| Electronic Health Record (EHR) |
0 |
0.06 |
| Electronic Medical Record |
0 |
0.06 |
| Fecal Transplant |
0 |
0.06 |
| Fibromyalgia |
0 |
0.06 |